Shanghai ZJ Bio-Tech Co. Ltd. A
Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. It offers nucleic acid and real-time PCR kits, as well as consumables. The company was founded in 2005 and is based in Shanghai, China.
Shanghai ZJ Bio-Tech Co. Ltd. A (688317) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.002x
Based on the latest financial reports, Shanghai ZJ Bio-Tech Co. Ltd. A (688317) has a cash flow conversion efficiency ratio of 0.002x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥6.85 Million) by net assets (CN¥3.39 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shanghai ZJ Bio-Tech Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Shanghai ZJ Bio-Tech Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shanghai ZJ Bio-Tech Co. Ltd. A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai ZJ Bio-Tech Co. Ltd. A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ:CTNM
|
-0.068x |
|
E&R Engineering
TWO:8027
|
0.062x |
|
International Personal Finance plc
PINK:IPFPF
|
0.010x |
|
Opple Lighting Co Ltd
SHG:603515
|
1.058x |
|
Liuzhou Liangmianzhen Co Ltd
SHG:600249
|
0.015x |
|
Dong Fang Offshore Co., Ltd.
TW:7786
|
0.293x |
|
Real Matters Inc
PINK:RLLMF
|
0.043x |
|
Rejlerkoncernen AB
F:3RE
|
0.055x |
Annual Cash Flow Conversion Efficiency for Shanghai ZJ Bio-Tech Co. Ltd. A (2013–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai ZJ Bio-Tech Co. Ltd. A from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.64 Billion | CN¥77.59 Million | 0.021x | +199.65% |
| 2023-12-31 | CN¥3.82 Billion | CN¥-81.88 Million | -0.021x | -115.37% |
| 2022-12-31 | CN¥4.20 Billion | CN¥584.97 Million | 0.139x | -16.97% |
| 2021-12-31 | CN¥3.83 Billion | CN¥641.94 Million | 0.168x | -78.52% |
| 2020-12-31 | CN¥1.46 Billion | CN¥1.14 Billion | 0.781x | +482.33% |
| 2019-12-31 | CN¥571.84 Million | CN¥76.66 Million | 0.134x | -11.44% |
| 2018-12-31 | CN¥532.66 Million | CN¥80.63 Million | 0.151x | +49.06% |
| 2017-12-31 | CN¥472.70 Million | CN¥48.00 Million | 0.102x | +10.36% |
| 2016-12-31 | CN¥483.90 Million | CN¥44.53 Million | 0.092x | +147.38% |
| 2015-12-31 | CN¥343.47 Million | CN¥12.78 Million | 0.037x | -85.11% |
| 2014-12-31 | CN¥110.35 Million | CN¥27.57 Million | 0.250x | +4.71% |
| 2013-12-31 | CN¥118.03 Million | CN¥28.16 Million | 0.239x | -- |